Should we recommend screening mammography for women aged 40 to 49?

ONCOLOGY

Volumn 10, Issue 3, 1996, Pages 357-364

  Esserman, Laura ^a,b,c   Kerlikowske, Karla ^b  

^a Breast Care Center

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mount Zion Cancer Center

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0030091965     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Fletcher SW, Black W, Harris R, et al: Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85:1644-1656, 1993.
2. Elwood JM, Cox B, Richardson AK: The effectiveness of breast cancer screening by mammography in younger women [published errata appear in Online J Curr Clin Trials Mar 55, 1993; Doc No 34: and Mar 31, 1994; Doc No 121.
3. Kerlikowske K, Grady D, Rubin SM, et al: Efficacy of screening mammography. A meta-analysis. JAMA 273:149-154, 1995.
4. Nystrom L, Rutqvist L, Wall S, et al: Breast cancer screening with mammography: Overview of Swedish randomized trials. Lancet 341(8851):973-978, 1993.
5. Tabar L, Fagerberg G, Chen H, et al: Efficacy of breast cancer screening by age: New results from the Swedish two-county trial. Cancer 75.2507-2517, 1995.
6. Chu KC, Smart CR, Tarone RE: Analysis of breast cancer mortality and stage distribution by age for the health insurance plan clinical trial. J Natl Cancer Inst 80: 1125-1132, 1988.
7. Smart CR, Hendrick RE, Rutledge JH, et al. Benefit of mammography screening in women 40-49 current evidence from randomized screening trials published erratum appears in Cancer 76:2788, 1995]. Cancer 75:1619-1626, 1995.
8. Miller AB, Baines CJ, To T, et al: Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 147:1459-1476, 1992.
9. Kerlikowske K, Grady D: Response to Smart CR, Hendrick E, Rutledge JH, and Smith, RA: Benefit of mammography screening in women ages 40 to 49 years: current evidence from randomized controlled trials. Cancer vol 76:1679-1680, 1995.
10. Shapiro S, Venet W, Strax, et al: Ten- to Fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 69:349-355, 1982.
11. Andersson I, Aspergren K, Janzon L, et al: Mammographic screening and mortality from breast cancer: The Malmo Mammographic Screening Trial. Br Med J 297:943-948, 1988.
12. Roberts MM, Alexander FE, Anderson TJ, et al: Edinburgh trial of screening for breast cancer: Mortality at seven years. Lancet 335(8684):241-246, 1990.
13. DeKoning HJ, Boer R, Warmerdam PG, et al: Quantitative Interpretation of Age-Specific Mortality Reductions from the Swedish Breast Cancer-Screening Trials J Natl Cancer Inst 87(16):1217-1223, 1995.
14. Moskowitz M: Breast Cancer: Age specific growth rates and screening strategies. Radiology 161:37-41, 1986.
15. Peer PGM, Holland R, Hendriks JHCL, et al: Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: Assessment of early indicators of screening effectiveness. J Natl Cancer Inst 86(6):436-441, 1994.
16. Sickles EA, Kopans DB: Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst 85:1621-24, 1993.
17. Bulpitt CJ. Meta-analysis. Lancet 2:93-94, 1988.
18. Petitti DB: Meta-analysis Decision Analysis and Cost-Effectiveness Analysis. New York, Oxford University Press, pgs 15-20, 1994.
19. Bird RE: Low-cost screening mammography: Report on finances and review of 21,716 consecutive cases. Radiology 171:87-90, 1989.
20. Linver MN, Paster SB, Rosenberg RD, et al: Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-Year medical audit of 38,633 cases. Radiology 184:39-43, 1992.
21. Burhenne HJ, Burhene LW, Goldberg F, et at: Interval breast cancers in the screening mammography program of British Columbia: Analysis and classification. Am J Roentgenol 162:1067-1071, 1994.
22. Robertson CL: A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 187:75-9, 1993.
23. Sienko DG, Hahn RA, Mills EM, et al: Mammography use and outcomes in a community. The greater Lansing area mammography study. Cancer 71:1801-1809, 1993.
24. Harris R, Leininger L: Clinical strategies for breast cancer screening: Weighing and using the evidence. Ann Intern Med 122.539-547, 1995.
25. Kerlikowske K, Grady D, Barclay J, et al. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270(20):2444-2450, 1993.
26. Lerman C, Trock B, Rimer BK, et al: Psychological and behavioral implications for abnormal mammograms. Ann Intern Med 114:657-661, 1991.
27. Cockburn J, Staples M, Hurley SF, et al: Psychological consequences of screening mammography. J Med Screening 1:7-12, 1994.
28. Ellman R, Angeli N, Christians A, et al Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 60:781-784, 1989.
29. Gram IT, Lund E, Slenker SE: Quality of life following a false positive mammogram. Br J Cancer 62:1018-1022, 1990.
30. Dixon J, Chetty U, Forrest A: Wound infection after breast biopsy. Br J Surg 75(9):918-919, 1988.
31. Helvie MA, Ikeda DM, Adler DD: Localization and needle aspiration of breast lesions. Am J Radiol 157:711-714, 1991.
32. Swanson MG, Ragheb NE, Lin CS, et al: Breast cancer among black and white women in the 1980s. Cancer 72:788, 1993.
33. Ernster VL, Barclay J, Kerlikowske K, et al: Breast ductal carcinoma in situ (DCIS): Trends in incidence and treatment and estimates of mastectomies for mammographically-detected DCIS in the United States. JAMA, 1996 (in press).
34. Stacey-Clear AM, McCarthy KA, Hall DA, et al: Breast cancer survival among women under age 50: Is mammography detrimental? Lancet 340:991-994, 1992.
35. Nielson M, Thomsen JL, Primdahl S, et al Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies. Br J Cancer 56:814-819, 1987
36. Fisher ER, Costantino J, Fisher B, et al. Response - Blunting the Counterpoint. Cancer 75(6), 1223-1227, 1995.
37. Page DL, Lagios MD: Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial. Cancer 75(6):1219-1222, 1995.
38. Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328(22):1581-1586, 1993.
39. Schwartz CF, Finkel GC, Garcia JC, et al Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 70:2468-74, 1992.
40. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer 75(6): 1310-1319, 1995.
41. Hetelekidis S, Schnitt SJ, Morrow M, et al: Management of ductal carcinoma in situ. CA Cancer J Clin 45(4):244-253, 1995.
42. Lagios MD, Margolin FR, Westdahl PR: Mammographically detected duct al carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618-624, 1989.
43. Baines CJ: The Canadian National Breast Screening Study: A perspective on criticisms. Ann Intern Med 120:326-34, 1994.
44. Esserman LJ, Alexander B, Flynn-Hollander S, et al: Setting targets for cost effective mammographic screening in the U.S. Presented at the 17th Annual San Antonio Breast Cancer Symposium. San Antonio, Texas. 1994.
45. Harris RP, Fletcher SW, Gonzalez JJ, et al: Mammography and age: Are we targeting the wrong women? A community survey of women and physicians. Cancer 67:2010-2014, 1991.
46. Moskowitz M: Guidelines for screening for breast cancer. Is a revision in order? Radiol Clin North Am 30(1):221-233, 1992.